Regenxbio (RGNX) Change in Receivables (2014 - 2025)

Regenxbio's Change in Receivables history runs 12 years deep, the most recent figure standing at $561000.0 for Q4 2025.

• On a quarterly basis, Change in Receivables rose 106.9% year-over-year to $561000.0 in Q4 2025; TTM through Dec 2025 was $7.7 million, a 178.92% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 178.92% from the prior year.
• Change in Receivables retreated to $561000.0 in Q4 2025 per RGNX's latest filing, from $6.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $10.7 million in Q2 2022 and bottomed at -$22.0 million in Q4 2021.
• The 5-year median for Change in Receivables is -$505500.0 (2025), against an average of -$1.2 million.
• Across the five-year window, Change in Receivables tumbled 251.61% in 2022 and jumped 788.73% in 2025, its largest moves.
• Year by year, Change in Receivables stood at -$22.0 million in 2021, then soared by 77.99% to -$4.8 million in 2022, then soared by 30.45% to -$3.4 million in 2023, then plunged by 141.41% to -$8.1 million in 2024, then soared by 106.9% to $561000.0 in 2025.
• Per Business Quant, the three latest RGNX Change in Receivables figures stand at $561000.0 (Q4 2025), $6.3 million (Q3 2025), and $2.4 million (Q2 2025).